GNTX · Gentex Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-21 | BROWN LESLIE L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | KENNEDY JOHN C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | WALKER BRIAN C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | Starkoff Kathleen |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | Pink Billy |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | DEUR GARTH |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | Zang Ling |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-21 | Schaum Richard O |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,626 |
| 2026-05-15 | ANDERSON JOSEPH B JR |
Director |
Sell↓
|
Common Stock
|
5,939 |
| 2026-05-15 | WALKER BRIAN C |
Director |
Sell↓
|
Common Stock
|
5,939 |
| 2026-05-05 | BROWN LESLIE L |
Director |
Convert↑
|
Non-Employee Director Stock Option Grant
|
7,000 |
| 2026-05-05 | BROWN LESLIE L |
Director |
Convert↑
|
Common Stock
|
7,000 |
| 2026-05-05 | BROWN LESLIE L |
Director |
Convert↑
|
Common Stock
|
7,000 |
| 2026-05-05 | BROWN LESLIE L |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $22.815 to $22.90. The price reported above reflects the weighted average price. |
Common Stock
|
10,782 |
| 2026-05-05 | BROWN LESLIE L |
Director |
Convert↑
|
Non-Employee Director Stock Option Grant
|
7,000 |
| 2026-04-30 | Schaum Richard O |
Director |
Convert↑
|
Common Stock
|
7,000 |
| 2026-04-30 | Schaum Richard O |
Director |
Convert↑
|
Non-Employee Director Stock Option Plan
|
7,000 |
| 2026-04-30 | Schaum Richard O |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $23.30 to $23.34. The price reported above reflects the weighted average price. |
Common Stock
|
4,815 |
| 2026-02-19 | Boehm Neil |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% three years from grant award date. |
Common Stock
|
14,953 |
| 2026-02-19 | Ryan Scott P |
General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% three years from grant award date. |
Common Stock
|
11,000 |
| 2026-02-19 | Chiodo Matthew |
Vice President of Sales |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% three years from grant award date. |
Common Stock
|
12,047 |
| 2026-02-19 | Downing Steven R |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% three years from grant award date. |
Common Stock
|
43,492 |
| 2026-02-19 | Nash Kevin C |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% three years from grant award date. |
Common Stock
|
13,880 |
| 2026-02-17 | Downing Steven R |
President and CEO |
Tax↓
|
Common Stock
|
14,018 |
| 2026-02-17 | Ryan Scott P |
General Counsel |
Sell↓
|
Common Stock
|
7,145 |
| 2026-02-17 | Downing Steven R |
President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
124,311 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
Common Stock
|
124,311 |
| 2026-02-17 | Ryan Scott P |
General Counsel |
Tax↓
|
Common Stock
|
11,492 |
| 2026-02-17 | Downing Steven R |
President and CEO |
Tax↓
|
Common Stock
|
54,314 |
| 2026-02-17 | Boehm Neil |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
Common Stock
|
31,993 |
| 2026-02-17 | Boehm Neil |
Chief Technology Officer |
Tax↓
|
Common Stock
|
14,160 |
| 2026-02-17 | Ryan Scott P |
General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
Common Stock
|
25,782 |
| 2026-02-17 | Nash Kevin C |
Chief Financial Officer |
Tax↓
|
Common Stock
|
4,306 |
| 2026-02-17 | Chiodo Matthew |
Vice President of Sales |
Tax↓
|
Common Stock
|
3,187 |
| 2026-02-17 | Chiodo Matthew |
Vice President of Sales |
Sell↓
|
Common Stock
|
4,122 |
| 2026-02-17 | Ryan Scott P |
General Counsel |
Sell↓
|
Common Stock
|
1,879 |
| 2026-02-17 | Chiodo Matthew |
Vice President of Sales |
Award↑
Filing footnotes — Common Stock (Direct)
28,269 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
Common Stock
|
28,269 |
| 2026-02-17 | Boehm Neil |
Chief Technology Officer |
Sell↓
|
Common Stock
|
2,332 |
| 2026-02-17 | Nash Kevin C |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. |
Common Stock
|
38,181 |
| 2026-02-17 | Nash Kevin C |
Chief Financial Officer |
Sell↓
|
Common Stock
|
5,568 |
| 2026-02-17 | Downing Steven R |
President and CEO |
Sell↓
|
Common Stock
|
35,000 |
| 2026-02-17 | Ryan Scott P |
General Counsel |
Tax↓
|
Common Stock
|
2,907 |
| 2026-02-17 | Nash Kevin C |
Chief Financial Officer |
Sell↓
|
Common Stock
|
6,317 |
| 2026-02-17 | Boehm Neil |
Chief Technology Officer |
Sell↓
|
Common Stock
|
8,916 |
| 2026-02-17 | Nash Kevin C |
Chief Financial Officer |
Tax↓
|
Common Stock
|
16,864 |
| 2026-02-17 | Chiodo Matthew |
Vice President of Sales |
Sell↓
|
Common Stock
|
15,705 |
| 2026-02-17 | Chiodo Matthew |
Vice President of Sales |
Tax↓
|
Common Stock
|
12,564 |
| 2026-02-17 | Boehm Neil |
Chief Technology Officer |
Tax↓
|
Common Stock
|
3,608 |
| 2025-08-26 | Nash Kevin C |
Chief Financial Officer |
Gift↓
Filing footnotes — Common Stock (Direct)
Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
Common Stock
|
865 |
| 2025-05-16 | ANDERSON JOSEPH B JR |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $22.65 to $23.07. The price reported above reflects the weighted average price. |
Common Stock
|
3,764 |
| 2025-05-15 | Zang Ling |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 100% one year from grant award date. |
Common Stock
|
5,939 |